During the past decade, The Trauma Center at PENN conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Trauma Center at PENN" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Trauma Center at PENN" are "Acute Kidney Injury" (1 trials), "Fournier's Gangrene" (1 trials), "Necrotizing Fasciitis" (1 trials), "Necrotizing Soft Tissue Infection" (1 trials) and "Necrotizing Soft Tissue Infections" (1 trials). Many other conditions were trialed in "The Trauma Center at PENN" in a lesser frequency.

Most popular intervention types in "The Trauma Center at PENN" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AB103 0.5 mg/kg" (1 trials), "NaCl 0.9%" (1 trials), "Placebo" (1 trials) and "Reltecimod 0.5 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Trauma Center at PENN" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The Trauma Center at PENN". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Trauma Center at PENN, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Trauma Center at PENN, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".